Physician profile
Kathleen Erin Kearney
NPI 1144459462
$448,374.19
in general payments reported to CMS, 2019-2025
23 companies · $58K in 2025
The $58K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $16K · 2021: $33K · 2022: $81K · 2023: $118K · 2024: $119K · 2025: $58K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $136K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $65K · Travel and Lodging: $47K · Honoraria: $23K · Food and Beverage: $18K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,900 · Grant: $1,635 · Education: $6.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $136,032.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $64,555.83 |
| Travel and Lodging | $47,183.14 |
| Honoraria | $22,855.83 |
| Food and Beverage | $17,966.65 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,900.00 |
| Grant | $1,634.90 |
| Education | $6.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $111,722.26 | 2019-2025 | Optis, Xience Skypoint, Diamondback Coronary |
| Medtronic, INC. | $93,555.18 | 2021-2025 | Resolute Onyx, Onyx Frontier, Symplicity G3 |
| Boston Scientific Corporation | $92,044.45 | 2019-2025 | General - Vascular Access, Rotapro, General - Ct_ic |
| Abiomed | $52,447.44 | 2020-2025 | Impella |
| Teleflex LLC | $24,880.48 | 2019-2025 | Turnpike, Guideliner, Arrow |
| Shockwave Medical, INC | $13,372.07 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Reflow Medical INC | $12,985.75 | 2023-2024 | |
| Cardiovascular Systems INC. | $10,981.79 | 2019-2023 | Diamondback Coronary |
| Philips North America LLC | $9,291.50 | 2022-2023 | (9520) Igt Devices Undivided |
| Vascular Solutions, INC. | $7,613.04 | 2019 | |
| Asahi Intecc USA, INC. | $5,629.29 | 2019-2025 | Asahi Coronary Wires, Asahi Ptca Guide Wire, Peripheral Vascular |
| Medtronic Vascular, INC. | $2,889.32 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $2,000.00 | 2023 | Lifevest |
| Arrow International, INC. | $1,972.94 | 2020-2024 | Guideliner |
| Biotronik INC. | $1,843.13 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,570.00 | 2025 | |
| Terumo Medical Corporation | $1,133.62 | 2024-2025 | Glidesheath Slender, Metacross Otw, Tr Band |
| Siemens Medical Solutions USA, INC. | $909.82 | 2020-2022 | |
| Verge Medical, INC. | $648.94 | 2024-2025 | Ostial Flash System |
| Corindus INC. | $520.50 | 2019 | |
| W. L. Gore & Associates, INC. | $123.41 | 2025 | Gore Cardioform Septal Occluder |
| Impulse Dynamics (USA) INC. | $122.18 | 2023 | Optimizer |
| Edwards Lifesciences Corporation | $117.08 | 2019-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Kearney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.